ASCENTAGE PHARMA GROUP INTERNATIONALAAPGEarnings & Financial Report
Nasdaq
AAPG Q4 2025 Key Financial Metrics
売上高
$574.1K
粗利益
N/A
営業利益
N/A
純利益
N/A
粗利益率
N/A
営業利益率
N/A
純利益率
N/A
前年比成長
N/A
資金フロー
ASCENTAGE PHARMA GROUP INTERNATIONAL Q4 2025 Financial Summary
ASCENTAGE PHARMA GROUP INTERNATIONAL reported revenue of $574.1K for Q4 2025, with a net profit of N/A (N/A margin). Cost of goods sold was N/A.
Key Financial Metrics
| Total Revenue | $574.1K |
|---|---|
| Net Profit | N/A |
| Gross Margin | N/A |
| Operating Margin | N/A |
| Report Period | Q4 2025 |
ASCENTAGE PHARMA GROUP INTERNATIONAL Quarterly Revenue & Net Profit History
ASCENTAGE PHARMA GROUP INTERNATIONAL quarterly results over the last 2 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 2025 | $574.1K | — | N/A | N/A |
| Q2 2025 | $32.6M | — | N/A | N/A |
損益計算書
| Q2 2025 | Q4 2025 | |
|---|---|---|
| 売上高 | $32.6M | $574120 |
| 前年比成長 | N/A | N/A |
貸借対照表
| Q2 2025 | Q4 2025 | |
|---|---|---|
| 総資産 | N/A | N/A |
| 総負債 | N/A | N/A |
| 株主資本 | N/A | N/A |
キャッシュフロー
No data available for this period